Madrigal Pharmaceuticals Inc (MDGL)
210.82
+6.80
(+3.33%)
USD |
NASDAQ |
May 01, 16:00
210.82
0.00 (0.00%)
After-Hours: 18:32
Madrigal Pharmaceuticals SG&A to Revenue (TTM)
SG&A to Revenue (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A to Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2012 | -- |
| December 31, 2011 | -- |
| September 30, 2011 | -- |
| June 30, 2011 | -- |
| March 31, 2011 | -- |
| December 31, 2010 | -- |
| September 30, 2010 | -- |
| Date | Value |
|---|---|
| June 30, 2010 | -- |
| March 31, 2010 | -- |
| December 31, 2009 | -- |
| September 30, 2009 | -- |
| June 30, 2009 | -- |
| March 31, 2009 | -- |
| December 31, 2008 | -- |
SG&A to Revenue Definition
SG&A to Revenue is a ratio that compares a company's Sales, General, and Administrative Expenses to its total revenue. SG&A to Revenue can be used to measure the efficiency of a company's cost management. SG&A expenses include costs such as salaries, marketing expenses, rent, utilities, office supplies, and other operational expenses that are not directly tied to the production of goods or services. By comparing these expenses to total revenue, the ratio helps assess how effectively a company...
SG&A to Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median